Y Beguin

3.2k total citations
39 papers, 1.1k citations indexed

About

Y Beguin is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Y Beguin has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 15 papers in Genetics and 10 papers in Immunology. Recurrent topics in Y Beguin's work include Hematopoietic Stem Cell Transplantation (18 papers), Hemoglobinopathies and Related Disorders (9 papers) and Erythropoietin and Anemia Treatment (8 papers). Y Beguin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Hemoglobinopathies and Related Disorders (9 papers) and Erythropoietin and Anemia Treatment (8 papers). Y Beguin collaborates with scholars based in Belgium, United States and France. Y Beguin's co-authors include Georges Fillet, Frédéric Baron, Mario Cazzola, Luisa Ponchio, F Baron, E. Willems, Laurence Seidel, Pascale Frère, Alexandra Briquet and Chantal Lechanteur and has published in prestigious journals such as The Lancet, Blood and Cancer.

In The Last Decade

Y Beguin

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Beguin Belgium 19 698 459 241 117 111 39 1.1k
Valeria Maria Pinto Italy 19 527 0.8× 648 1.4× 120 0.5× 115 1.0× 96 0.9× 57 1.0k
F. Hernández‐Navarro Spain 21 991 1.4× 441 1.0× 65 0.3× 80 0.7× 195 1.8× 58 1.4k
Renu Saxena India 21 967 1.4× 417 0.9× 68 0.3× 133 1.1× 68 0.6× 123 1.3k
Annelies E. van Ede Netherlands 10 479 0.7× 344 0.7× 107 0.4× 82 0.7× 40 0.4× 19 1.1k
Jan Hastka Germany 15 584 0.8× 373 0.8× 40 0.2× 126 1.1× 100 0.9× 42 1.0k
Patricia Griffith United States 12 1.1k 1.6× 952 2.1× 103 0.4× 90 0.8× 92 0.8× 14 1.4k
Mariasanta Napolitano Italy 22 711 1.0× 337 0.7× 55 0.2× 148 1.3× 69 0.6× 117 1.3k
Matthew F. Whelihan United States 14 481 0.7× 197 0.4× 188 0.8× 224 1.9× 73 0.7× 22 1.0k
Nicola Piccirillo Italy 14 330 0.5× 184 0.4× 145 0.6× 86 0.7× 176 1.6× 67 715
Ching-Tien Peng Taiwan 20 346 0.5× 513 1.1× 127 0.5× 173 1.5× 101 0.9× 42 999

Countries citing papers authored by Y Beguin

Since Specialization
Citations

This map shows the geographic impact of Y Beguin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Beguin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Beguin more than expected).

Fields of papers citing papers by Y Beguin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Beguin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Beguin. The network helps show where Y Beguin may publish in the future.

Co-authorship network of co-authors of Y Beguin

This figure shows the co-authorship network connecting the top 25 collaborators of Y Beguin. A scholar is included among the top collaborators of Y Beguin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Beguin. Y Beguin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Erpicum, Pauline, Marlies E. J. Reinders, Soufian Meziyerh, et al.. (2024). Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?. Frontiers in Genetics. 15. 1436194–1436194.
3.
Grégoire, Céline, Pascale Huynen, Stéphanie Gofflot, et al.. (2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports. 12(1). 9790–9790. 2 indexed citations
4.
Beguin, Y, Cécile Borel, Bénedicte Bruno, et al.. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l’hôte : rapport de la SFGM-TC. Pathologie Biologie. 62(4). 197–203. 7 indexed citations
5.
Moermans, Catherine, E. Willems, Frédéric Baron, et al.. (2014). Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation. 49(11). 1382–1388. 11 indexed citations
6.
Chevallier, Patrice, Myriam Labopin, Nöel Milpied, et al.. (2013). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation. 49(3). 361–365. 12 indexed citations
7.
Castermans, Emilie, Jacques Dutrieux, Stéphanie Humblet‐Baron, et al.. (2010). Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica. 96(2). 298–306. 62 indexed citations
9.
Castermans, Emilie, Frédéric Baron, E. Willems, et al.. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica. 93(2). 240–247. 25 indexed citations
10.
Beguin, Y & Frédéric Baron. (2003). MINITRANSPLANTS: ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED TOXICITY. Acta Clinica Belgica. 58(1). 37–45. 1 indexed citations
11.
Frère, Pascale, et al.. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 29(7). 589–594. 16 indexed citations
12.
Baron, Frédéric & Y Beguin. (2002). Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 8(7). 351–359. 25 indexed citations
13.
Fillet, Georges & Y Beguin. (2001). MONITORING OF ERYTHROPOIESIS BY THE SERUM TRANSFERRIN RECEPTOR AND ERYTHROPOIETIN. Acta Clinica Belgica. 56(3). 146–154. 10 indexed citations
14.
Ribbens, Clio, et al.. (2000). Effective treatment of Jo‐1‐associated polymyositis with T‐cell‐depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology. 110(2). 339–342. 31 indexed citations
15.
Baron, Frédéric & Y Beguin. (2000). Adoptive immunotherapy with donor lymphocyte infusionsafter allogeneic HPC transplantation. Transfusion. 40(4). 468–476. 24 indexed citations
16.
Beguin, Y. (1998). A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer. Drug Safety. 19(4). 269–282. 20 indexed citations
18.
Beguin, Y. (1995). Erythropoiesis and Erythropoietin in Multiple Myeloma. Leukemia & lymphoma. 18(5-6). 413–421. 30 indexed citations
20.
Beguin, Y, Clemons Gk, Pensri Pootrakul, & Georges Fillet. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood. 81(4). 1067–1076. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026